Ology Bioservices, Inc Overview
Company Headquarters: Florida, US
Founded: 1999
Workforce: ~800
Company Working: Ology Bioservices, Inc. is an integrated biopharmaceutical company that develops and manufactures biopharmaceuticals and medical devices. It specializes in cell therapy, gene therapy, viral vectors, antibodies, oncolytic viruses, biopharmaceutical manufacturing, and vaccines. It has collaboration and partnerships with recognized government agencies, namely the Department of Defense and Medical Countermeasures Advanced Development and Manufacturing, which support it in developing biodefense products. Moreover, it has decades of experience in developing, licensing, and manufacturing proteins, therapeutics, and vaccines. It develops products to offer both commercial customers and US governments.
Furthermore, it is a wholly owned company of National Resilience, Inc. (US), and assisting Resilience through its services includes regulatory support from preclinical through licensure and cGMP manufacturing up to biosafety level 3 (BSL3).
Strategy
Ology Bioservices, Inc. is emphasizing providing unique and innovative products associated with medical countermeasures. It is focusing on building relations with government agencies and collaborating with them to develop biodefense products to fulfill the local, national, and international needs of the government. Moreover, it is raising funds to meet the emergency demand of the government for biodefense products and signing contracts. Furthermore, it is focusing on forming major strategic alliances to commercialize and assist the government in combating emerging diseases.
